Outcomes deliver disappointment for vaccine advocates but progress on paediatric access to biologics

At its March 2026 meeting, the Pharmaceutical Benefits Advisory Committee delivered a set of recommendations, including recommendations for paediatric Crohn disease, but there was disappointment for those wanting broader access to a meningococcal vaccine that is now funded by some states. …